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Introduction: The optimization of an organic scaffold for specific types of applications and cells is vital to
successful tissue engineering. In this study, we investigated the effects of a new fibrin sealant derived from snake
venom as a scaffold for mesenchymal stem cells, to demonstrate the ability of cells to affect and detect the
biological microenvironment.
Methods: The characterization of CD34, CD44 and CD90 expression on mesenchymal stem cells was performed by
flow cytometry. In vitro growth and cell viability were evaluated by light and electron microscopy. Differentiation
into osteogenic, adipogenic and chondrogenic lineages was induced.
Results: The fibrin sealant did not affect cell adhesion, proliferation or differentiation and allowed the adherence
and growth of mesenchymal stem cells on its surface. Hoechst 33342 and propidium iodide staining demonstrated
the viability of mesenchymal stem cells in contact with the fibrin sealant and the ability of the biomaterial to
maintain cell survival.
Conclusions: The new fibrin sealant is a three-dimensional scaffolding candidate that is capable of maintaining cell
survival without interfering with differentiation, and might also be useful in drug delivery. Fibrin sealant has a low
production cost, does not transmit infectious diseases from human blood and has properties of a suitable scaffold
for stem cells because it permits the preparation of differentiated scaffolds that are suitable for every need.Introduction
Successful cell therapy requires the identification of ap-
propriate cells for the intended purpose [1]. Mesenchy-
mal stem cells (MSCs) are the most commonly used
cells in tissue engineering [2-4] and are found in several
organic compartments, including the bone marrow, blood
vessels, skin, and fat and muscle tissues [5]. MSCs can dif-
ferentiate into osteogenic cells [6-8], chondrogenic cells
[8,9], adipogenic cells [10] and cardiogenic cells [11] in re-
sponse to different stimuli.* Correspondence: rseabra@cevap.org.br
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distribution, and reproduction in any mediumMSCs are distinguished by their phenotype: MSCs ex-
press the cell surface markers CD73, CD90 and CD105
and are negative for CD11b, CD14, CD34, CD45 and hu-
man leukocyte antigen-DR [8].
The main strategy to deliver stem cells or growth fac-
tors to chronic wounds involves direct injection to the
injury site. However, this method leads to poor engraft-
ment and poor efficacy due to proteolytic degradation
within the first few hours post injection, thus preventing
the beneficial effects of these expensive biological agents
[12]. In the field of tissue engineering, ideal scaffolds
that permit cells to proliferate and differentiate without
interference have been sought recently [3]. The main
features of such scaffolds include the promotion of cell ad-
hesion, mechanical support [13] and biodegradability [3].
Fibrin sealants have various applications in tissue engin-
eering and could act as drug delivery vehicles and scaf-
folding matrices in surgical procedures [14] and might
participate in inflammatory infiltrate chemotaxis during le-
sion repair [15-17]. According to Buchta and colleaguestral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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processes, reduce blood loss and protect against bacterial
infections. Additionally, the two components of fibrin seal-
ants can be mixed and processed in different ways [19].
Bensaid and colleagues showed that MSCs that were
seeded into fibrin scaffolds and subsequently grafted into
mice could create extensive networks of blood vessels
and fibroblasts, a result that was not observed when the
sealant alone was grafted [20].
Fibrin sealant (FS), an innovative product derived from
snake venom, is produced only from animal components
and thus does not transmit human blood-borne infectious
diseases. Moreover, the production costs are lower than
those of commercial sealants [16]. This study thus evalu-
ated the first use of FS as a cellular scaffold and demon-
strated the effects of this biomaterial on the maintenance,
induction, differentiation, integrity and viability of MSCs.
Methods
Fibrin sealant scaffold
Commercially available fibrin sealants consist of human
thrombin and fibrinogen, which might transmit infec-
tious diseases [16]. Researchers at the Center for the Study
of Venoms and Venomous Animals at UNESP (Centro de
Estudos de Venenos e Animais Peçonhentos da UNESP),
São Paulo State University therefore proposed a new seal-
ant produced from the thrombin-like enzyme extracted
from snake venom and animal fibrinogen. The sealant was
produced in this study according to the proposed stan-
dardization [15-17,21]. The product was provided in three
microtubes that were stored at −20°C. Upon use, the com-
ponents were mixed in the previously set proportions to
generate a stable clot with a dense fibrin network.
Mesenchymal stem cell expansion and characterization
Wistar rat MSCs were cultured in Dulbecco’s modified
Eagle medium (high glucose; Gibco Laboratories, Grand
Island, NY, USA) supplemented with 20% fetal bovine
serum (Sigma-Aldrich, St Louis, MO, USA), 100 UI/ml
penicillin, 100 μg/ml streptomycin solution (Gibco La-
boratories) and 3 μg/ml amphotericin B (Gibco Laborato-
ries) [22,23]. The experiments were performed according
to the Brazilian College for Animal Experimentation
(COBEA) guidelines and were approved by the Univer-
sity’s Ethics Committee in Experimental Animal Use
(CEEA/FMB/UNESP, protocol number 811/2010).
First-passage MSCs were characterized by surface mar-
kers to determine the ratio between the MSCs and the
hematopoietic stem cells in the culture. The results were
analyzed with a flow cytometer (FACSCalibur; BD, San
Jose, CA, USA) that was located at the Blood Center of the
School of Medicine Botucatu (Hemocentro da Faculdade
de Medicina de Botucatu). CD44 (HCAM OX50 FITC;
Santa Cruz Biotechnology, Delaware Avenue, CA, USA)and CD90 (mouse anti-rat FITC; Gibco Laboratories) anti-
bodies were used as positive markers for MSCs and a
CD34 antibody (mouse anti-human FITC; BD Pharmingen,
San Diego, CA, USA) was used as a negative marker.
The cell suspensions were adjusted so that each test
had 1 × 105 cells. The cells were distributed into five
tubes (Falcon; BD Pharmingen) and were stained as fol-
lows: unstained cells (control 1), cells with only secondary
antibody (control 2) and cells with either CD44, CD90 or
CD34 antibodies.
The antibodies of CD44, CD90 and CD34 were added
at a dilution of 1:10 for 30 minutes at room temperature.
After antibody addition, 1 ml phosphate-buffered saline
(PBS) was added to wash the cells and they were centri-
fuged at 2,000 rpm (620 × g) for 10 minutes. The super-
natant was discarded and the pellet resuspended in 1 ml
PBS. The CD44 marker was not conjugated and a sec-
ondary antibody was then added, waiting for 30 minutes
before the supernatant was discarded and the pellet re-
suspended in 1 ml PBS. Finally the tubes were read on a
flow cytometer (FACSCalibur; BD).
Cell differentiation
The ability of the MSCs to differentiate into osteogenic,
chondrogenic and adipogenic tissues was tested. The
StemPro Adipogenesis Differentiation Kit, the StemPro
Chondrogenesis Differentiation Kit and the StemPro
Osteogenesis Differentiation Kit (all Invitrogen Life Sci-
ence Technologies, Carlsbad, CA, USA) were used to
differentiate MSCs into adipogenic, chondrogenic and
osteogenic tissues, respectively. The kits were used ac-
cording to the manufacturer’s instructions.
Differentiation into the adipogenic lineage
When the cell culture reached 70% confluence, the com-
plete culture medium was replaced with a specific differ-
entiation medium that contained 90% StemPro Adipocyte
Differentiation Basal Medium (Invitrogen Life Science
Technologies), 10% StemPro Adipogenesis Supplement
(Invitrogen Life Science Technologies), 100 UI/ml penicil-
lin, 100 μg/ml streptomycin and 3 μg/ml amphotericin B
(Invitrogen Life Science Technologies). The differentiation
medium was replaced every 3 days during a 7-day period
of differentiation. After this procedure, the cells were fixed
in 4% paraformaldehyde, washed in PBS and distilled
water and then stained with 2 ml Oil Red-O solution
(Invitrogen Life Science Technologies, Carlsbad, CA,
USA). The cells were incubated for 40 minutes at room
temperature, after which the dye was subsequently re-
moved and the cells were washed three times in distilled
water. Two milliliters of hematoxylin solution were added
to the cells for 15 minutes to label the nuclei. The wells
were washed again with distilled water and the fields were
observed under an inverted light microscope.
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When the cell culture reached 70% confluence, the com-
plete culture medium was replaced with a specific differen-
tiation medium that contained 90% StemPro Osteocyte/
Chondrocyte Differentiation Basal Medium (Invitrogen Life
Science Technologies), 10% StemPro Chondrogenesis Sup-
plement (Invitrogen Life Science Technologies), 100 UI/ml
penicillin, 100 μg/ml streptomycin and 3 μg/ml amphoteri-
cin B (Invitrogen Life Science Technologies). The differenti-
ation medium was replaced every 3 days for a total of 16
days of differentiation. After this procedure, the cells were
fixed in 4% paraformaldehyde, washed in PBS and stained
in 2 ml of 1% Alcian Blue (Sigma-Aldrich) in 0.1 N the cells
were washed three times in HCl (Sigma-Aldrich) 0.1 N.
The cells were incubated for 30 minutes at room
temperature, after which the dye was removed, the cells
were washed three times in 0.1 N hydrogen chloride
(Sigma) and the fields were observed under an inverted
light microscope.
Differentiation into the osteogenic lineage
When the cell culture reached 70% confluence, the com-
plete culture medium was replaced with a specific differen-
tiation medium that contained 90% StemPro Osteocyte/
Chondrocyte Differentiation Basal Medium, 10% StemPro
Chondrogenesis Supplement, 100 UI/ml penicillin, 100 μg/
ml streptomycin and 3 μg/ml amphotericin B. The differen-
tiation medium was replaced every 3 days for a total of 10
days of differentiation. After this procedure, the cells were
fixed in ice-cold 70% ethanol, washed in distilled water and
stained in 2 ml Alizarin Red (Invitrogen Life Science Tech-
nologies, Carlsbad, CA, USA). The cells were incubated for
30 minutes at room temperature, after which the dye was
removed, the cells were washed four times in water and the
fields were observed under an inverted light microscope.In vitro spontaneous MSC differentiation in the presence
of the biomaterial
The induction of spontaneous cell differentiation in the
presence of FS was assessed after 20 days of MSC growth
in the presence of the biomaterial. The specific markers
that were described above for osteogenic, chondrogenic
and adipogenic cell lineages were used to assess cell
differentiation.
Fibrin sealant and MSC formulations
Eight microliters of FS were added into six-well culture
plates along with 3.20 × 105 rat MSCs that had been cul-
tured and characterized as described previously, followed
by the addition of complete culture medium. The plates
were kept in an incubator at 37.5°C in a humid atmosphere
with 5% CO2. The maintenance medium was replaced
every 5 days.Inverted light microscopy
The growth and interaction of MSCs (2.13 × 103 cells/ml)
with the biomaterial were evaluated in the first passage
culture plates by inverted light microscopy.
Fluorescence microscopy
Cells that grew on the biomaterial were evaluated for
growth and viability after labeling with fluorescent probes.
The cells were stained with Hoescht 33342 and propidium
iodide (Sigma-Aldrich) to label live cells in blue and dead
cells in red, respectively.
The medium and FS were removed from the MSC pri-
mary cell culture plate, and 0.5 ml PBS and 20 μl of 10 mg/
ml Hoescht 33342 solution were added to the plate for 10
minutes, after which the PBS and Hoescht solution were
discarded and the cells were washed with fresh PBS. Five μl
of a 1 mg/ml propidium iodide solution were added to the
plate and incubated for 5 minutes, after which the cells
were washed again with PBS before analyzing the labeled
cells with a fluorescence microscope (450 to 490 nm).
Scanning electron microscopy
Sealant samples were cultured together with MSCs and
were subsequently fixed in Karnovysky’s fixative (1%
paraformaldehyde, 2.5% glutaraldehyde in 0.1 M phos-
phate buffer solution, pH 7.3) for 24 hours.
After the fixation step, the samples were washed with
0.1 M phosphate buffer, pH 7.3 (3× 5-minute washes),
subjected to post-fixation in 1% osmium tetroxide diluted
in the same buffer for 3 hours, dehydrated in increasing
concentrations of ethanol up to a final concentration of
100%, transferred from a 70% concentration directly into
absolute ethanol (this was repeated 3 times), dried in a
CPD030 critical point apparatus with liquid carbon diox-
ide, mounted on appropriate stubs and, finally, metallized
and gold-coated in a Sputter SCD050 (Leica Microsystems
Inc. Buffalo Grove, IL. USA).
The analyses were performed with a JEOL Scanning
Electron Microscope (JSM5800 LV; JEOL. Tokyo, Japan)
at a voltage of 10 kV and were recorded as digital photo-
graphs by the same apparatus.
Transmission electron microscopy
Sealant samples were cultured with MSCs and fixed in
Karnovysky’s fixative (1% paraformaldehyde, 2.5% glutar-
aldehyde in 0.1 M phosphate buffer solution, pH 7.3) for
24 hours.
After fixation, the samples were washed with 0.1 M
phosphate buffer, pH 7.3 (3× 5-minute washes), sub-
jected to post-fixation in 1% osmium tetroxide diluted in
the same buffer for 3 hours, dehydrated in increasing con-
centrations of ethanol up to a final concentration of 100%,
immersed in acetone for 1 hour, immersed in acetone/resin
(2:1) for 12 hours, immersed in acetone/resin (1:1) for 12
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(Sigma-Aldrich). Embedded samples were polymerized in
an oven at 50°C for 48 hours. Sections were cut with appro-
priate blades and stained as follows: 0.3 μm semi-thin sec-
tions were cut with a glass knife and stained with 1%
Toluidine Blue on a hotplate, and 50 nm ultra-thin sections
were cut with a diamond knife and stained with Manila/
lead citrate (SPI Supplies. West Chester, PA. USA).
The analyses were performed with a TECNAI BIOT
WEEN G2 SPIRIT Transmission Electron Microscope
(FEI Company, Hillsboro, OR. USA) at a voltage of 80 kV




The material formed a dense fibrin network that resulted
in a stable clot approximately 2 minutes after the recon-
stitution of its components at room temperature.
Mesenchymal stem cell expansion and characterization
MSCs from the primary culture were able to adhere to
plastic, as confirmed by flow cytometry after the first
passage. The flow cytometry results indicated that 1.36%
of the cells expressed CD34 and 89.06% and 81.93%
expressed CD90 and CD44, respectively, as shown inFigure 1 Flow cytometric characterization of mesenchymal stem cells
characterization of mesenchymal stem cells (MSCs) with (A) negative (CD3
selected for analyses. FSC, forward scatter; LL, lower left; LR, lower right; SSCFigure 1A,B,C. Figure 1D shows the cell population se-
lected for analyses.
No difference was observed in the cell growth rate
after 12 days and 90% confluence regardless of the pres-
ence of FS. The average number of MSCs isolated in the
first passage was approximately 6.41 × 105.
Differentiation into the adipogenic lineage
Lipid-rich vacuoles formed within the first-passage MSCs
after 7 days of culture in specific differentiation media.
These changes were noted by the presence of red-colored
vacuoles that confirmed the adipogenic lineage (Figure 2).
There was no significant labeling of intracellular lipids
in MSCs after 7 days of culture in the presence of FS,
which indicated that the biomaterial alone could not
induce the differentiation of MSCs to the adipogenic
lineage.
Differentiation into the chondrogenic lineage
Proteoglycans produced by first-passage MSC chondro-
cytes were observed after 16 days of culture in specific
differentiation media. These changes were noted by the
presence of blue staining that confirmed the chondro-
genic lineage (Figure 3).
There was no significant chondrogenic cell labeling
after 16 days of MSC culture in the presence of FS,with negative and positive markers. Flow cytometric
4) and (B, C) positive (CD90 and CD44) markers. (D) Cell population
, side scatter; UL, upper left; UR, upper right.
Figure 2 Mesenchymal stem cell adipogenic differentiation
potential. Adipogenic differentiation (Oil Red-O (Invitrogen Life
Science Technologies, Carlsbad, CA, USA); 400× magnification).
Figure 4 Mesenchymal stem cell osteogenic differentiation
potential. Osteogenic differentiation (Alizarin Red (Invitrogen Life
Science Technologies, Carlsbad, CA, USA); 200× magnification).
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the differentiation of MSCs to the chondrogenic lineage.
Differentiation into the osteogenic lineage
Calcium deposits were found in the MSC cultures after
10 days in specific differentiation media. The deposits
were detected by the presence of red staining that la-
beled the mineral deposits in the extracellular medium
and thus confirmed differentiation to the osteogenic
lineage (Figure 4).
Low-intensity but significant staining was observed
after 10 days of MSC culture in the presence of FS.
Three additional 20-day cultures were performed. No la-
beling was observed in the MSC cultures in the presence
or absence of the biomaterial prior to reaching max-
imum confluence. However, mineralization was observedFigure 3 Mesenchymal stem cell chondrogenic differentiation
potential. Chondrogenic differentiation (Alcian Blue (Sigma-Aldrich,
St Louis, MO, USA); 400× magnification).in MSC cultures that were maintained for a long period
at maximum confluence in the absence of FS. Cell label-
ing thus confirmed MSC differentiation to the osteo-
genic lineage in the absence of the biomaterial.
Evaluation by inverted light microscopy
MSCs were mixed with FS after the first passage from
the primary culture. The proliferation of cells with fibro-
blastoid morphology, including those around the bioma-
terial, was noted on the second day of culture. Cell
confluence during this period was approximately 30 to
40%.
The cells proliferated while maintaining their morpho-
logical characteristics and definition between the FS and
MSCs after 4 days of culture. Maximum cell confluence
in the cultures was 60 to 70%. The fibrin network formed
by the FS displayed a cobweb appearance in some regions
due to the presence of cells captured by the fibrin network
(Figure 5).
The cell cultures were 90% confluent after 8 days in
culture, and some of the MSCs adhered to and grew on
the FS surfaces.
Evaluation by fluorescence microscopy
Viable cells were indicated by bright blue Hoescht
33342-stained nuclei. Cells with damaged membranes
were stained red by propidium iodide. MSC viability
was determined to be 80 to 85% in the presence of
FS (Figure 6).
Evaluation by scanning electron microscopy
The three-dimensional scanning electron microscopy
analysis of FS alone revealed a uniform surface in which
FS had formed a mat that primarily consisted of a dense
fibrin network (Figure 7).
Figure 5 Fibrin network that promotes mesenchymal stem cell
capture. Fibrin network with a cobweb appearance that promotes
mesenchymal stem cell capture (200× magnification).
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rial after 8 days of MSC culture indicated the ability of
FS to capture and promote cell adhesion on its surface
(Figure 8). Interactions between adjacent cells and the
presence of cellular extensions towards the interior of
the biomaterial were observed at a higher magnification
(Figure 9).
Evaluation by transmission electron microscopy
The presence of cellular projections in regions where
numerous layers had formed was observed during the
analysis of images of the biomaterial acquired after 8Figure 6 Cell viability analysis of mesenchymal stem cells
cultured in the presence of fibrin sealant. Hoescht 33342 and
propidium iodine (Sigma-Aldrich, St Louis, MO, USA) staining for the
cell viability analysis of mesenchymal stem cells cultured in the
presence of fibrin sealant. (200× magnification).days of MSC culture on FS. The presence of cell nuclei,
deposited matrix, possible original fibrin matrix and cir-
cular electrodense structures, which were characterized
as mitochondria, were also observed. The images showed
intimate connections between the MSCs and the scaffold,
and thus it was possible to show contacts between the bio-
material interfaces and the MSCs (Figure 10).
Discussion
MSCs are widely used because the cellular phenotype re-
mains undifferentiated and the differentiation potential
is maintained during long-term in vitro cultivation [6].
According to Bydlowski and colleagues, MSCs can dif-
ferentiate into osteoblasts, chondrocytes and adipocytes
both in vivo and in vitro [24]. This observation agrees
with the results shown in this study, in which MSCs de-
rived from rat bone marrow differentiated into the os-
teogenic, adipogenic and chondrogenic lineages.
Fu and colleagues showed that bone marrow MSC-
derived neural stem cells expressed the characteristic
MSC antigens CD29, CD44, CD73, CD90, CD105 and
CD166 [25]. Furthermore, the MSCs could proliferate and
differentiate into multiple mesodermal lineages. Mehlhorn
and colleagues used fluorescein-conjugated CD34, CD45,
CD90 and CD105 antibodies to characterize MSCs [26].
In the present study, MSCs of rat origin expressed high
levels of CD44 and CD90 and low levels of CD34 as deter-
mined by flow cytometry. These findings are in agreement
with the results reported by Fu and colleagues [25] and by
Mehlhorn and colleagues [26].
According to Ahmed and colleagues, the most com-
monly used fibrin derivatives in tissue engineering are
hydrogels, sealants and fibrin microbeads [3]. The new
biomaterial FS, derived from snake venom, was first used
as a biological scaffold and was shown to have optimal
plasticity and an excellent ability to interact with MSCs.
The ability of FS to induce the spontaneous differenti-
ation of MSCs into the adipogenic and chondrogenic
lineages was thus evaluated. No intracellular lipid de-
posit formation by adipocytes or proteoglycan produc-
tion by chondrocytes was observed, indicating that the
sealant did not directly affect MSC differentiation.
The onset of spontaneous differentiation to the osteo-
genic lineage in the presence of FS was as determined by
significant Alizarin Red staining of osteoblasts. When a
similar culture was prepared in low-glucose complete
medium without FS and allowed to reach maximum
confluence during a 20-day period, MSCs also differenti-
ated into osteogenic lineage cells. These results confirm
that the MSCs were driven to differentiate by a long cul-
ture period at maximum confluence rather than by the
presence of the biomaterial. The undifferentiated MSCs
might also have been stimulated to differentiate to the
osteogenic lineage as a result of the collection site or the
Figure 7 Dense fibrin network formed by the fibrin sealant. (4,000× magnification).
Gasparotto et al. Stem Cell Research & Therapy 2014, 5:78 Page 7 of 10
http://stemcellres.com/content/5/3/78presence of bone cell contaminants. The inability of FS
to induce differentiation and the neutrality of FS in MSC
culture were therefore again demonstrated.
The interaction of cells with the FS surface, which was
observed by optical microscopy and scanning electron
microscopy, showed large amounts of MSC adherence
and growth on the dense fibrin network formed by
the sealant. Gardin and colleagues also noted this phe-
nomenon and reported interactions between adipose
tissue-derived stem cells and scaffolds produced from tra-
ditionally prepared FS and hyaluronic acid [27].Figure 8 Fibrin sealant and mesenchymal stem cells adhered to the s
presence of a large amount of mesenchymal stem cells adhered to the surTransmission electron microscopy showed the presence
of nuclei with euchromatic features, which highlighted ac-
tive protein synthesis along with high metabolic activity.
We report the existence of interactions between viable
and actively functional MSCs and the FS, due to the clear
presence of deposited matrix. These results are corrobo-
rated by Trubiani and colleagues, who reported extensive
MSC biomass growth on scaffolds, including a fibrin
sponge [28].
A cell viability test with markers for live (Hoescht 33342)
and dead (propidium iodide) cells indicated viability ratesurface of the biomaterial. Mat formed by the fibrin sealant and the
face of the biomaterial (400× magnification).
Figure 9 Cellular prolongations towards the interior of the fibrin sealant. (4,000× magnification).
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Such a result ensures the presence of excellent inter-
actions between the cells and the scaffold (FS) because
the cells were able to maintain their viability and func-
tionality. This result corroborates an earlier report by
Yamada and colleagues that showed the possibility of
transferring MSCs to receptor sites without losses in
cellular structure integrity or viability of the cultured
tissue [29]. Yamada and colleagues also showed that
stem cells could effectively migrate and interact onFigure 10 Cell nucleus and deposited matrix formed by fibrin sealant
deposited matrix formed by fibrin sealant (arrows) (3,000× magnification).different scaffolds derived from traditionally prepared
fibrin sealants [29].
Several in vivo studies have been performed in differ-
ent animal species and humans, demonstrating the
translational potential of our FS [16,30,31].
Conclusions
The snake venom-derived FS produced at the Center for
the Study of Venoms and Venomous Animals at UNESP
interacts very well with rat bone marrow-derived MSCs.. Cellular projections with the presence of the cell nucleus (stars) and
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cording to MSC needs, thus enabling use with autolo-
gous, homologous or heterologous fibrinogen. Based on
the results, this new FS is a promising biological three-
dimensional scaffold candidate – and because the pro-
duct is derived from animals, FS does not transmit infec-
tious diseases from human blood.
Abbreviations
FS: fibrin sealant; MSC: mesenchymal stem cell; PBS: phosphate-buffered
saline.
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